Transgenomic, Inc. (NASDAQ:TBIO) Announces Licensing Agreement With LifeLabs, How Will Investors React to the News?

Transgenomic, Inc. (NASDAQ:TBIO) Announces Licensing Agreement With LifeLabs, How Will Investors React to the News?

Global biotechnology company advancing personalized medicine in oncology and inherited diseases through advanced diagnostic technologies, Transgenomic, Inc. (NASDAQ:TBIO), announces it has reached a licensing agreement with Canada’s LifeLabs. OMAHA, Neb.–(BUSINESS WIRE)– Transgenomic, Inc. (TBIO) (TBIO), today announced a licensing agreement with leading Canadian laboratory services provider LifeLabs, which has selected Transgenomic’s ICE COLD-PCR (ICP) technology as its mutation enrichment platform for cancer testing. The three-year, renewable agreement includes a non-exclusive […]

Read More ˃